Can You Get Cancer in Your Knee? Signs, Diagnosis & Treatment

Cancer can and does develop in and around the knee joint, though it is uncommon compared with cancers in organs like the lung, breast, or colon. The knee is actually one of the more frequent skeletal sites for primary bone tumors, particularly osteosarcoma and giant cell tumors, and soft tissue sarcomas can arise in the muscles, tendons, and synovial lining surrounding the joint. Because knee pain is so common and usually has a mundane explanation, the challenge is not whether knee cancer exists but how to recognize the warning signs before a treatable problem becomes a serious one.

What Types of Cancer Affect the Knee

The knee region can host several distinct kinds of cancer. Primary bone tumors, the kind that originate in the bone itself, tend to favor the area around the knee because the distal femur (lower end of the thighbone) and proximal tibia (upper shinbone) are among the most metabolically active zones of bone growth. Osteosarcoma, the most common primary malignant bone tumor in young people, has a particular affinity for these locations. Giant cell tumors of bone, which are technically aggressive but usually not malignant, also cluster around the knee.

Soft tissue cancers represent a separate category. These tumors develop in the muscles, fat, nerves, or the synovial membrane lining the joint. Synovial sarcoma, despite its name, does not necessarily arise from the synovium itself but often appears near joints, and case reports document it growing directly within the knee joint cavity.¹ Myxoid liposarcoma and nerve sheath tumors are other soft tissue malignancies reviewed in the literature on tumors around the knee.²

Finally, cancer that starts elsewhere in the body can spread to the bones around the knee. This is called metastatic disease and is distinct from a primary knee cancer. Even the kneecap (patella) can be a landing site for metastatic cells, with lung and kidney cancers reported more frequently than others as the original source.³ Patellar metastases are rare enough to be published as individual case reports, but they illustrate the principle that no bone is truly immune.

How Knee Cancer Feels at First

The earliest symptom of a primary bone tumor near the knee is almost always pain. A qualitative study of adults eventually diagnosed with primary bone tumors around the knee found a consistent pattern: pain starts intermittent and relatively mild, then gradually becomes more severe and more constant over weeks to months. Initially the pain tends to behave mechanically, worsening with activity and easing with rest, which is exactly how routine overuse injuries feel. Over time, though, the pain becomes harder to settle down, and rest or standard treatments like ice and anti-inflammatories stop helping.⁴

Night pain is one of the more distinctive warning signals. In a study of osteosarcoma patients, all reported pain as their first symptom. About half found it worse during weight-bearing, but more than a third described it as worse at night. Swelling typically appeared a mean of seven weeks after pain began.⁵ That lag is part of what makes early recognition so difficult: for several weeks, the patient may have nothing but vague knee pain that could be a dozen benign things.

Systemic symptoms like fever, weight loss, or fatigue are uncommon with bone tumors around the knee, at least early on. The absence of “feeling sick” often reinforces the assumption that the problem is a sports injury or arthritis. What should raise a red flag is the trajectory of the pain: a knee problem that simply will not improve over a reasonable time frame despite appropriate treatment deserves a closer look.

Why Knee Cancer Gets Mistaken for a Sports Injury

Misdiagnosis is a documented problem. At one major musculoskeletal oncology center, roughly 4% of all knee tumors had previously been misdiagnosed as athletic injuries, and some patients had even undergone arthroscopic surgery before anyone realized a tumor was present. Among those 25 patients, 14 turned out to have malignant tumors. The most common factors behind the wrong diagnosis were poor-quality initial X-rays and a failure to reconsider the diagnosis when symptoms persisted despite treatment.⁶

Soft tissue tumors can be even trickier. A synovial sarcoma growing inside the knee joint of a 26-year-old man, for instance, caused chronic posterior knee pain and a bending restriction that went on for over a year before diagnosis. On MRI, the mass looked well-defined and fairly bland, mimicking something benign. Synovial sarcomas under five centimeters often lack the aggressive-looking features that prompt immediate alarm on imaging.¹

Benign conditions that affect the knee’s synovial lining add to the confusion. Pigmented villonodular synovitis (PVNS), a condition where the joint lining grows abnormally, produces swelling, pain, and stiffness that overlap with rheumatoid arthritis, juvenile arthritis, and simple cysts. Because of this overlap, PVNS is frequently misdiagnosed or caught late.⁷ PVNS is not cancer, but the diagnostic confusion it causes illustrates why tumors near the knee can hide in plain sight.

How Knee Tumors Are Diagnosed

Conventional X-rays remain the first step for anyone with persistent knee pain, and they can catch many bone lesions that would otherwise go unnoticed. Plain radiographs are considered the essential first-line investigation for bone tumors around the knee, and they form one leg of the diagnostic “tripod” alongside clinical history and tissue analysis.⁸ When X-rays reveal a suspicious lesion, or when symptoms persist despite normal X-rays, MRI is the standard next step. MRI excels at showing the extent of a tumor within bone and surrounding soft tissue, which is critical for surgical planning.

After imaging identifies a suspicious mass, a biopsy is needed to determine whether it is benign or malignant and, if malignant, what specific type. How the biopsy is done matters. A study comparing open (surgical) biopsies to percutaneous core needle biopsies in sarcoma patients found that open biopsies carried a 32% rate of tumor cell seeding along the biopsy tract, compared to under 1% for needle biopsies.⁹ This is why musculoskeletal oncology guidelines strongly favor needle biopsy, and why it is important that the biopsy be planned by or in consultation with the surgeon who will ultimately perform the definitive operation. A poorly placed biopsy tract can complicate future surgery.

Surgery for Knee Tumors

If a tumor around the knee is malignant, surgery is typically the cornerstone of treatment. The goal has shifted dramatically over the past few decades. Where amputation was once the default for bone sarcomas near the knee, limb-salvage surgery is now the standard whenever tumor removal can be accomplished with adequate margins while preserving a functional leg.

Limb-salvage procedures usually involve removing the tumor-bearing segment of bone (and any involved soft tissue) and reconstructing the gap with a metal endoprosthesis, essentially an internal replacement joint. A study following patients who received endoprosthetic replacement of the distal femur after tumor resection reported a five-year prosthetic survival rate of about 88% and a mean functional score rated as good to excellent, though about a quarter of patients eventually died from distant metastases that were unrelated to the local surgery.¹⁰ Infection around the prosthesis and mechanical loosening are the most common surgical complications.

For giant cell tumors, which are usually benign but locally aggressive, surgeons often try to preserve the natural joint. Curettage (scraping out the tumor cavity) followed by filling the void with bone cement is a common approach. In one series of giant cell tumors around the knee that had caused pathological fractures, all fractures healed, the local recurrence rate was 12%, and 84% of patients achieved excellent functional scores.¹¹ Use of a high-speed burr during the procedure was linked to a lower recurrence rate.

Achieving clear surgical margins is critical for preventing local recurrence. Computer-assisted navigation is one tool that helps surgeons cut precisely, especially important in younger patients where preserving growth plates or as much healthy bone as possible matters enormously. In one series of bone sarcoma patients treated with image-guided navigation, clear margins were achieved in every case, with the narrowest bone margin being six millimeters, and no patient experienced local recurrence during follow-up.¹²

When a tumor has weakened bone to the point of causing a fracture around the knee, knee arthroplasty (a type of joint replacement) is sometimes used as the primary treatment. Patients in this situation tend to arrive in severe pain and with very limited function. In one study, 87% of patients reported severe pain before surgery, but none reported severe pain afterward, and functional scores improved substantially.¹³

Chemotherapy and Radiation

Osteosarcoma, the most common primary malignant bone tumor around the knee, is typically treated with chemotherapy before and after surgery. The standard backbone combines methotrexate, doxorubicin (Adriamycin), and cisplatin, often referred to as the MAP regimen. The large international EURAMOS-1 trial tested whether adding ifosfamide and etoposide to MAP would improve outcomes for patients whose tumors responded poorly to initial chemotherapy. It did not: three-year event-free survival was about 55% in both groups, and adding the extra drugs provided no meaningful benefit.¹⁴ This remains a frustrating reality in osteosarcoma care: the core chemotherapy regimen has not changed much in decades, and intensifying it has not reliably improved survival.

Neoadjuvant chemotherapy (given before surgery) also serves a diagnostic purpose. The degree to which the tumor has died off in response to chemo, assessed when the specimen is removed, is one of the strongest predictors of long-term outcome. In one series, multi-drug chemotherapy achieved 90% or greater tumor necrosis in about 86% of patients, and three-year overall survival was roughly 81%.¹⁵

Radiation therapy plays a more limited role around the knee than in many other cancer sites, partly because bone sarcomas like osteosarcoma are relatively resistant to radiation. For soft tissue sarcomas of the knee, though, radiation is used more regularly, either before or after surgery. A retrospective review found that adjuvant radiation for soft tissue sarcomas of the knee was relatively well tolerated. Joint stiffness occurred more often in irradiated patients, but moderate to severe stiffness affected only a small number.¹⁶

Targeted Therapies for Certain Knee Tumors

One area where treatment has genuinely advanced in recent years is tenosynovial giant cell tumor (TGCT), also known by its older name, PVNS. This is not technically a cancer but a locally aggressive tumor that can cause severe joint destruction, and it has a strong tendency to recur after surgery. For patients whose disease cannot be fully removed without unacceptable damage to the joint, targeted drugs that block the CSF1/CSF1R signaling pathway have proven effective. Two CSF1R inhibitors, pexidartinib and vimseltinib, are now approved in the United States for TGCT, with additional agents in clinical development.¹⁷ This is a meaningful option for people facing repeated surgeries or potential joint sacrifice.

When the Patient Is a Child or Teenager

Bone sarcomas around the knee disproportionately affect young people, especially those in their second decade of life. This creates a surgical challenge that adults do not face: the patient is still growing. Removing a segment of the femur or tibia and replacing it with a standard metal prosthesis in a ten-year-old would leave them with a significant leg-length difference by the time they finish growing.

Expandable endoprostheses were developed to address this. These devices can be lengthened periodically, either through minor surgical procedures or, in newer designs, noninvasively using an external magnetic mechanism. Chemotherapy and limb-salvage surgery together produce good oncologic outcomes in these young patients, and expandable prostheses are effective at maintaining functional leg-length equality.¹⁸

That said, complication rates remain high. In one long-term series of 38 children under 14 who received expandable endoprostheses, complications were documented in 58% of patients, with infection being the most common. About 55% of patients survived long-term, and among survivors, 71% had satisfactory function. The younger the child at surgery, the sooner the prosthesis tended to fail, reflecting the greater cumulative stress of years of growth and activity.¹⁹ These numbers have improved with newer prosthetic designs, but families should understand that keeping a growing child’s reconstructed limb functional is a long-term project involving multiple procedures, not a single operation.

Physical and emotional functioning in these patients is generally described as good, though complication rates remain a persistent concern.²⁰

Life After Knee Tumor Surgery

Even when surgery is successful and the cancer is gone, the reconstructed knee does not perform like the original. A systematic review and meta-analysis of biomechanical outcomes after endoprosthetic reconstruction for tumors around the knee confirmed that patients walk differently than healthy individuals. Gait parameters, knee muscle strength, and physical activity levels were all reduced, while the energy cost of walking was higher.²¹ Rehabilitation aims to maximize strength and mobility, but the knee will likely have some permanent limitations in range of motion and power.

The psychological side of recovery is more encouraging than many people expect. Children who underwent limb salvage with expandable prostheses reported high emotional satisfaction, excellent perceptions of body image and physical attractiveness, and no difficulty making friends or socializing with peers.²² Among adult survivors of osteosarcoma, studies comparing limb-salvage patients to those who had amputation found no significant differences in quality of life, body image, self-esteem, or social support between the two groups. The one exception: patients who initially had limb salvage but later required amputation because the reconstruction failed reported significantly worse body image than those in either a planned-amputation or successful-salvage group.²³ This finding underscores the importance of honest conversations about the realistic chances of reconstruction success before committing to a limb-salvage plan.

When to Push for More Answers

Most knee pain is not cancer. Arthritis, ligament sprains, meniscal tears, tendinitis, and bursitis account for the vast majority of visits to a doctor for knee complaints. But the pattern described by patients who turned out to have bone tumors is worth committing to memory: pain that starts mild and intermittent, gradually becomes more constant, stops responding to the usual remedies, and sometimes worsens at night.⁴ A lump or visible swelling that was not there before adds urgency. And any time a knee problem is being treated as an injury or strain but is not improving over a reasonable period, it is worth going back and asking whether something has been missed. The misdiagnosis data from one center found that a failure to revisit the original diagnosis when symptoms persisted was one of the most common reasons tumors were caught late.⁶ An X-ray is cheap and quick. If it has not been done, or if the first one was low quality, ask for it. If the X-ray is normal but the pain trajectory is not, ask about MRI. Being persistent is not being difficult; it is how cancers get caught at a stage where treatment can still be straightforward.